EASL Clinical Practice Guidelines on hepatitis E virus infection

被引:430
|
作者
Dalton H.R.
Kamar N.
Baylis S.A.
Moradpour D.
Wedemeyer H.
Negro F.
机构
[1] EASL, EASL Bldg Home Hepatol,7 Rue Daubin, CH-1203 Geneva, Switzerland
关键词
PEGYLATED INTERFERON-ALPHA; CHRONIC LIVER-DISEASE; NON-B HEPATITIS; KIDNEY-TRANSPLANT; RIBAVIRIN TREATMENT; IGG SEROPREVALENCE; BLOOD-DONORS; NON-A; EXTRAHEPATIC MANIFESTATIONS; VIROLOGICAL RESPONSE;
D O I
10.1016/j.jhep.2018.03.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Infection with hepatitis E virus (HEV) is a significant cause of morbidity and mortality, representing an important global health problem. Our understanding of HEV has changed completely over the past decade. Previously, HEV was thought to be limited to certain developing countries. We now know that HEV is endemic in most high-income countries and is largely a zoonotic infection. Given the paradigm shift in our understanding of zoonotic HEV and that locally acquired HEV is now the commonest cause of acute viral hepatitis in many European countries, the focus of these Clinical Practice Guidelines will be on HEV genotype 3 (and 4). (C) 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1256 / 1271
页数:16
相关论文
共 50 条
  • [1] EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
    Mutimer, David
    Aghemo, Alessio
    Diepolder, Helmut
    Negro, Francesco
    Robaeys, Geert
    Ryder, Stephen
    Zoulim, Fabien
    JOURNAL OF HEPATOLOGY, 2014, 60 (02) : 392 - 420
  • [2] EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
    Craxi, Antonio
    Pawlotsky, Jean-Michel
    Wedemeyer, Heiner
    Bjoro, Kristian
    Flisiak, Robert
    Forns, Xavier
    Mondelli, Mario
    Peck-Radosavljevic, Marcus
    Rosenberg, William
    Sarrazin, Christoph
    JOURNAL OF HEPATOLOGY, 2011, 55 (02) : 245 - 264
  • [3] EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
    Lampertico P.
    Agarwal K.
    Berg T.
    Buti M.
    Janssen H.L.A.
    Papatheodoridis G.
    Zoulim F.
    Tacke F.
    JOURNAL OF HEPATOLOGY, 2017, 67 (02) : 370 - 398
  • [4] EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
    Papatheodoridis, George
    Buti, Maria
    Cornberg, Markus
    Janssen, Harry
    Mutimer, David
    Pol, Stanislas
    Raimondo, Giovanni
    JOURNAL OF HEPATOLOGY, 2012, 57 (01) : 167 - 185
  • [5] The summarized of EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
    Idilman, Ramazan
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2017, 28 (05): : 412 - 416
  • [6] EASL Clinical Practice Guidelines on hepatitis delta virus br
    European Assoc Study Liver
    JOURNAL OF HEPATOLOGY, 2023, 79 (02) : 433 - 460
  • [7] EASL Clinical Practice Guidelines: Autoimmune hepatitis
    Lohse, Ansgar W.
    Chazouilleres, Olivier
    Dalekos, George
    Drenth, Joost P. H.
    Heneghan, Michael
    Hofer, Harald
    Lammert, Frank
    Lenzi, Marco
    JOURNAL OF HEPATOLOGY, 2015, 63 (04) : 971 - 1004
  • [8] Management of special patient groups with hepatitis B virus infection: The EASL 2017 Clinical Practice Guidelines
    Idilman, Ramazan
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2017, 28 (06): : 518 - 521
  • [9] Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection
    Kanda, Tatsuo
    Li, Tian-Cheng
    Takahashi, Masaharu
    Nagashima, Shigeo
    Primadharsini, Putu Prathiwi
    Kunita, Satoshi
    Sasaki-Tanaka, Reina
    Inoue, Jun
    Tsuchiya, Atsunori
    Nakamoto, Shingo
    Abe, Ryuzo
    Fujiwara, Keiichi
    Yokosuka, Osamu
    Suzuki, Ryosuke
    Ishii, Koji
    Yotsuyanagi, Hiroshi
    Okamoto, Hiroaki
    HEPATOLOGY RESEARCH, 2024, 54 (08) : 1 - 30